US2949402A - Tablet coating - Google Patents

Tablet coating Download PDF

Info

Publication number
US2949402A
US2949402A US728776A US72877658A US2949402A US 2949402 A US2949402 A US 2949402A US 728776 A US728776 A US 728776A US 72877658 A US72877658 A US 72877658A US 2949402 A US2949402 A US 2949402A
Authority
US
United States
Prior art keywords
coating
tablets
parts
film
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US728776A
Inventor
Mehrabi-Nejad Shahriar
Grunigen Alfred Charles De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Priority to US728776A priority Critical patent/US2949402A/en
Application granted granted Critical
Publication of US2949402A publication Critical patent/US2949402A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Definitions

  • This invention relates to an improvement in the art of coating pharmaceutical tablets.
  • the invention includes the method of coating the tablets, the new coating composition employed therein as well as tablets coated with the novel composition.
  • Coating pharmaceutical tablets containing therapeutically active substances has been practiced in the art for many years.
  • the most common coating for pharmaceutical tablets has been sugar which is applied as an aqueous syrup to the pressed tablets as they are tumbling in a rotating coating pan while they are being dried by a current of air blown over their surface.
  • sugar-coated tablets have been known and used for many years, they are subject to a number of disadvantages. An effective coating over the sharp edges of the pressed tablets is difiicult to obtain, and a large number of individual coats is required. Because of the aqueous nature of the sugar syrup, drying of the tablets while being coated is a very slow operation; and several days are required to obtain satisfactory coating. This, of course, adds greatly to the expense of the finished product.
  • a number of other disadvantages associated With sugar coating of pharmaceutical tablets could be mentioned, but it is suflicient to say that there is a very definite need for an improved method of coatingtablets containing medicinal substances.
  • Medicinal tablets are coated for a number of different reasons-to disguise the taste and the odor of the medicinal substances, to protect the contents of the tablet from the action of the atmosphere and other external factors, to improve their appearance, to give them added strength,
  • a coating for pharmaceutical tablets must possess a number of distinct and important properties to be acceptable for this purpose.
  • the coating must be nontoxic and otherwise physiologically acceptable. It should be sufiiciently flexible to withstand the tumbling action of the coating operation and in subsequent handling of the coated tablets. It must, of course, be film forming so as to completely cover the tablet to be coated. It should have the property of forming a thin film.
  • the film should be tasteless and colorless. It should mix easily with coloring and flavoring agents. It should be comparatively hard and non-tacky and non-hygroscopic. It should be capable of covering the sharp edges of the tablets as well as indentations thereon which may be pressed into the tablet to provide lines of breakage or identification marks.
  • the present invention is predicated upon our discovery that hydroxypropylglycerol, a viscous, almost colorless liquid, made by reacting glycerin and propylene oxide so that the resulting compound has an available hydroxypropyl substitution of about 2.5, can be used in coating compositions of the kind just discussed to provide cornpatibility of the hydrophilic component with the filmforming component whereby an almost perfect coating of medicinal tablets can be achievedand which will remain in this perfect condition on handling and over a long period of time.
  • the film-forming component of the coating composition of the present invention is preferably a cellulose dicarboxylic acid ester such as cellulose acetate phthalate, as is disclosed in United States Patent No. 2,093,462, is sued September 21, 1937, to Malm et al.
  • Other filmforming cellulose esters of dicarboxylic acid such as are disclosed in this patent and United States Patent No. 2,093,464 may also be used in practicing the coating process of the present invention.
  • the hydrophilic component of our coating composition is preferably one of the polyalkylene glycols such as polyethylene glycol or polypropylene glycol having a molecular weight of about 6000 or more.
  • the film-forming substance such as cellulose acetate phthalate is dissolved in a suitable'organic solvent together with the hydroxypropyl glycerol to form a solution or dispersion.
  • a dispersing agent such as sorbitan monooleate
  • Another solution containing the polyalkylene glycol is also prepared in a suitable organic solvent to form a solution which is compatible with the first-described solution.
  • the two solutions are then mixed to form a coating dispersion which is then used to coat the medicinal tablets in a conventional coating pan.
  • the coating solution is first applied as a dilute solution for the first few coats and thereafter is added to the coating pan in a more concentrated form.
  • the coating solution is non-aqueous and contains solvents which are readily volatile, a single coating on the tumbling tablets is dried in a matter of minutes. As many coatings may be applied to the tablets as desired. As few as five individual coats may be sutficient applied with the concentrated formulation. .coats were applied in order to successfully mask the taste in some instances wher'eas as many as seventy-five or more individual coats can be applied to the tablets if desired.
  • the first few layers are applied with a dilute solution. Then the remainder of the layers required are Seventeen of the medicament. This required about fifty minutes. After the last coat was applied, tumbling was prolonged for about fifteen minutes to insure complete drying.
  • the tablets werethen ready'for packaging. They possessed a hi h luster and were very uniformly coated. The markings on the original uncoated tablet could very conveniently be seen because of the clear nature of the coating material. 'I'he'distintegratingtime in water was five minutes.
  • cellulose acetate phthalate of the above example there may be used from about 100 to 400 parts by weight of the hydrophilic component, polyethylene glycol of the above.
  • the proportions of 4 hydroxypropylglycerol are critical to achieve the maximum advantages of this component.
  • the amount of the hydroxypropylglycerol will vary somewhat with the proportion of polyalkylene glycol in the composition but will normally range from about 25 to 50 parts by weight of the film-forming component.
  • dispersing agent sorbitanmonooleate
  • organic solvents used to dissolve the essential components of the coating composition are not critical. They should, of course, be reasonably volatile in order that the coating operation may be carried out rapidlyland serve .as solvents for the several components of the composition. Various solvents and mixtures thereof will occur to those skilled in the We claim: 1
  • a method of coating pharmaceutical tablets which comprises the steps of applying to said tablets, while they are tumbling in a tablet coating pan, a solution containing a cellulose ester of a dicarboxylic acid as a film-forming substance and for each hundred parts thereof from to 400 parts by weight of a polyalkylene glycoland from 25 to 50 parts by weight of hydroxypropylglycerol.
  • a method of coating pharmaceutical tablets which comprises the steps of applying to said tablets a nonaqueous solution comprising a volatile organic solvent, a cellulose ester of a dicarboxylic acid as a film-forming substance, and for each hundred parts thereof, 100 to 400 parts by weight of polyethylene glycol and 25 to 50 parts by weight of hydroxypropylglycerol.
  • a method of coating pharmaceutical tablets which comprises the steps of applying to said tablets .a nonaqueous solution containing cellulose acetate phthalate and for each hundred parts thereof, 100 to 400parts by weight of polyethylene glycol and from 25 to 50 parts by weight of hydroxypropylglycerol.
  • a method of coating pharmaceutical tablets which comprises the steps of applying to said tablets a nonaqucous solution containing cellulose acetate phthalate and for each hundred parts thereof, 100 to 400 parts by weight of polyethylene glycol and about 35 parts by weight of hydroxypropylglycerol.

Description

United States Patent TABLET COATING Shahriar Mehrabi-Neiad, Pearl River, and Alfred 'Charles De Grunigen, Nanuet, N.Y., assignors to American Cyanamid Company, New York, N.Y., a corporation of Maine No Drawing. Filed Apr. 16, 1958, Ser. No. 728,776
4 Claims. (Cl. 167-82) This invention relates to an improvement in the art of coating pharmaceutical tablets. The invention includes the method of coating the tablets, the new coating composition employed therein as well as tablets coated with the novel composition.
Coating pharmaceutical tablets containing therapeutically active substances has been practiced in the art for many years. The most common coating for pharmaceutical tablets has been sugar which is applied as an aqueous syrup to the pressed tablets as they are tumbling in a rotating coating pan while they are being dried by a current of air blown over their surface. While sugar-coated tablets have been known and used for many years, they are subject to a number of disadvantages. An effective coating over the sharp edges of the pressed tablets is difiicult to obtain, and a large number of individual coats is required. Because of the aqueous nature of the sugar syrup, drying of the tablets while being coated is a very slow operation; and several days are required to obtain satisfactory coating. This, of course, adds greatly to the expense of the finished product. A number of other disadvantages associated With sugar coating of pharmaceutical tablets could be mentioned, but it is suflicient to say that there is a very definite need for an improved method of coatingtablets containing medicinal substances.
Medicinal tablets are coated for a number of different reasons-to disguise the taste and the odor of the medicinal substances, to protect the contents of the tablet from the action of the atmosphere and other external factors, to improve their appearance, to give them added strength,
reduce dusting, l y their rate of disintegration, and ny other reasons. I i
A coating for pharmaceutical tablets must possess a number of distinct and important properties to be acceptable for this purpose. The coating must be nontoxic and otherwise physiologically acceptable. It should be sufiiciently flexible to withstand the tumbling action of the coating operation and in subsequent handling of the coated tablets. It must, of course, be film forming so as to completely cover the tablet to be coated. It should have the property of forming a thin film. The film should be tasteless and colorless. It should mix easily with coloring and flavoring agents. It should be comparatively hard and non-tacky and non-hygroscopic. It should be capable of covering the sharp edges of the tablets as well as indentations thereon which may be pressed into the tablet to provide lines of breakage or identification marks. These and other requirements of an acceptable pharmaceutical tablet coating are difiicult to obtain.
The desirability of avoiding aqueous tablet coating compositions and the development of coatings which can be applied in a short period of time have been appreciated for some time and a number ofefforts have been made to provide coatings for medicinal tablets which have more desirable properties than those previously available. Film-forming substances when dissolved inhighly volatile organic solvents and applied to tablets by conventional coating procedures are not generally satisfactory because they do not meet one or more of the above-indicated requirements of a satisfactory tablet-coating material. Generally it is necessary to include in the coating composition a hydrophilic component which will enable the stomach fluids to penetrate the film provided by the film-forming component of the composition. Unfortunately, however, the film-forming substances and the hydrophilic component of the coating are often incompatible and as a result the coating soon cracks or disintegrates and presents a very undesirable appearance and may even separate completely from the pressed tablet.
The present invention is predicated upon our discovery that hydroxypropylglycerol, a viscous, almost colorless liquid, made by reacting glycerin and propylene oxide so that the resulting compound has an available hydroxypropyl substitution of about 2.5, can be used in coating compositions of the kind just discussed to provide cornpatibility of the hydrophilic component with the filmforming component whereby an almost perfect coating of medicinal tablets can be achievedand which will remain in this perfect condition on handling and over a long period of time.
The film-forming component of the coating composition of the present invention is preferably a cellulose dicarboxylic acid ester such as cellulose acetate phthalate, as is disclosed in United States Patent No. 2,093,462, is sued September 21, 1937, to Malm et al. Other filmforming cellulose esters of dicarboxylic acid such as are disclosed in this patent and United States Patent No. 2,093,464 may also be used in practicing the coating process of the present invention. The hydrophilic component of our coating composition is preferably one of the polyalkylene glycols such as polyethylene glycol or polypropylene glycol having a molecular weight of about 6000 or more.
In practicing the coating process of the present invention, the film-forming substance such as cellulose acetate phthalate is dissolved in a suitable'organic solvent together with the hydroxypropyl glycerol to form a solution or dispersion. Small amounts of a dispersing agent, such as sorbitan monooleate, to facilitate mixing of the essential components of the solution are usually added. Another solution containing the polyalkylene glycol is also prepared in a suitable organic solvent to form a solution which is compatible with the first-described solution. The two solutions are then mixed to form a coating dispersion which is then used to coat the medicinal tablets in a conventional coating pan. Usually the coating solution is first applied as a dilute solution for the first few coats and thereafter is added to the coating pan in a more concentrated form.
Because the coating solution is non-aqueous and contains solvents which are readily volatile, a single coating on the tumbling tablets is dried in a matter of minutes. As many coatings may be applied to the tablets as desired. As few as five individual coats may be sutficient applied with the concentrated formulation. .coats were applied in order to successfully mask the taste in some instances wher'eas as many as seventy-five or more individual coats can be applied to the tablets if desired.
Since each coating operation takes only a few minutes, it will be seen that'theentire coating operation can be completed in a matter of hours rather thandays as is required inusing an aqueous sugar syrup as the coating material.
In order that the coating process of the present invention vmayibe more readily understood, a preferred embodiment of. the invention will be given by way of example:
After the above solutions are prepared, they are then mixed. r
1500 standard convex scored medicated tablets having a trade name'stamped thereon were placed on an 8-inch Colton coating pan and then tumbled. As the tablets were tumbling, a dilute solution of the hydroxypropylglycerol formulation (diluted with a 25 percent solution of a 50/50 mixture v./v. of acetone and ethyl alcohol) was poured into the tumbling pan in an amount suflicient to cover the tablets (in this case about to 10 milliliters). These were tumbled for exactly two minutes, then a second portion of dilute coating solution was added while tumbling, and the tablets tumbled for another two min utes. Four or five additional coats were applied at twominute intervals (21 longer drying time is not harmful). Usually, the first few layers are applied with a dilute solution. Then the remainder of the layers required are Seventeen of the medicament. This required about fifty minutes. After the last coat was applied, tumbling was prolonged for about fifteen minutes to insure complete drying. The tablets werethen ready'for packaging. They possessed a hi h luster and were very uniformly coated. The markings on the original uncoated tablet could very conveniently be seen because of the clear nature of the coating material. 'I'he'distintegratingtime in water was five minutes.
For each 100 parts by weight of the film-forming component of the coating mixture, cellulose acetate phthalate of the above example, there may be used from about 100 to 400 parts by weight of the hydrophilic component, polyethylene glycol of the above. The proportions of 4 hydroxypropylglycerol are critical to achieve the maximum advantages of this component.
mixed together and on drying the hydroxypropylglycerol tends to act as a plasticizer keeping the remaining components of the coating compatible, thus avoiding cracking and disintegrating of the film after it has been dried. The amount of the hydroxypropylglycerol will vary somewhat with the proportion of polyalkylene glycol in the composition but will normally range from about 25 to 50 parts by weight of the film-forming component.
The amounts of dispersing agent, sorbitanmonooleate above, are not critical and likewise the organic solvents used to dissolve the essential components of the coating composition are not critical. They should, of course, be reasonably volatile in order that the coating operation may be carried out rapidlyland serve .as solvents for the several components of the composition. Various solvents and mixtures thereof will occur to those skilled in the We claim: 1
l. A method of coating pharmaceutical tablets which comprises the steps of applying to said tablets, while they are tumbling in a tablet coating pan, a solution containing a cellulose ester of a dicarboxylic acid as a film-forming substance and for each hundred parts thereof from to 400 parts by weight of a polyalkylene glycoland from 25 to 50 parts by weight of hydroxypropylglycerol.
2. A method of coating pharmaceutical tablets which comprises the steps of applying to said tablets a nonaqueous solution comprising a volatile organic solvent, a cellulose ester of a dicarboxylic acid as a film-forming substance, and for each hundred parts thereof, 100 to 400 parts by weight of polyethylene glycol and 25 to 50 parts by weight of hydroxypropylglycerol.
3. A method of coating pharmaceutical tablets which comprises the steps of applying to said tablets .a nonaqueous solution containing cellulose acetate phthalate and for each hundred parts thereof, 100 to 400parts by weight of polyethylene glycol and from 25 to 50 parts by weight of hydroxypropylglycerol.
4. A method of coating pharmaceutical tablets which comprises the steps of applying to said tablets a nonaqucous solution containing cellulose acetate phthalate and for each hundred parts thereof, 100 to 400 parts by weight of polyethylene glycol and about 35 parts by weight of hydroxypropylglycerol.
References Cited in the file of this patent UNITED STATES PATENTS 2,798,023 Berger July 2, 1957 FOREIGN PATENTS 484,600 Great Britain May 9, 1939 762,229 Great Britain Nov. 28, 1956 The amount should be sufficient to form a compatible solution of the filmforming component and the hydrophilic component when solutions of these substances are prepared and Y

Claims (1)

1. A METHOD OF COATING PHARMACEUTICAL TABLETS WHICH COMPRISES THE STEPS OF APPLYING TO SAID TABLETS, WHILE THEY ARE TUNBLING IN A TABLET COATING PAN, A SOLUTION CONTAINING A CELLULOSE ESTER OF A DICARBOXYLIC ACID AS A FILM-FORMING SUBSTANCE AND FOR EACH HUNDRED PARTS THEREOF FROM 100 TO 400 PARTS BY WEIGHT OF A POLYALKYLENE GLYCOL AND FROM 25 TO 50 PARTS BY WEIGHT OF HYDROXYPROPYLGLYCEROL.
US728776A 1958-04-16 1958-04-16 Tablet coating Expired - Lifetime US2949402A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US728776A US2949402A (en) 1958-04-16 1958-04-16 Tablet coating

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US728776A US2949402A (en) 1958-04-16 1958-04-16 Tablet coating

Publications (1)

Publication Number Publication Date
US2949402A true US2949402A (en) 1960-08-16

Family

ID=24928237

Family Applications (1)

Application Number Title Priority Date Filing Date
US728776A Expired - Lifetime US2949402A (en) 1958-04-16 1958-04-16 Tablet coating

Country Status (1)

Country Link
US (1) US2949402A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3131068A (en) * 1961-07-24 1964-04-28 American Cyanamid Co Water-soluble coated edible organic acids
US3324038A (en) * 1964-04-17 1967-06-06 Procter & Gamble Detergent composition
US3371015A (en) * 1962-06-28 1968-02-27 Haessle Ab Pharmaceutical core compositions with thin rapidly disintegrating coatings
US3379554A (en) * 1964-04-21 1968-04-23 Merck & Co Inc Spray coating of pharmaceutical cores with a carboxylvinyl polymer and polyethylene glycol
US3431138A (en) * 1967-07-14 1969-03-04 American Cyanamid Co Method for coating pharmaceutical forms with methyl cellulose
EP0283165A2 (en) * 1987-03-06 1988-09-21 The Procter & Gamble Company Skin conditioning composition and method
US5194464A (en) * 1988-09-27 1993-03-16 Takeda Chemical Industries, Ltd. Enteric film and preparatoin thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB484600A (en) * 1935-11-09 1938-05-09 Ig Farbenindustrie Ag Manufacture of shaped medicinal preparations
GB762229A (en) * 1953-11-09 1956-11-28 Abbott Lab Improvements in or relating to coated tablets and to compositions adapted for application to tablets
US2798023A (en) * 1957-07-02 zapapas etal

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798023A (en) * 1957-07-02 zapapas etal
GB484600A (en) * 1935-11-09 1938-05-09 Ig Farbenindustrie Ag Manufacture of shaped medicinal preparations
GB762229A (en) * 1953-11-09 1956-11-28 Abbott Lab Improvements in or relating to coated tablets and to compositions adapted for application to tablets

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3131068A (en) * 1961-07-24 1964-04-28 American Cyanamid Co Water-soluble coated edible organic acids
US3371015A (en) * 1962-06-28 1968-02-27 Haessle Ab Pharmaceutical core compositions with thin rapidly disintegrating coatings
US3324038A (en) * 1964-04-17 1967-06-06 Procter & Gamble Detergent composition
US3379554A (en) * 1964-04-21 1968-04-23 Merck & Co Inc Spray coating of pharmaceutical cores with a carboxylvinyl polymer and polyethylene glycol
US3431138A (en) * 1967-07-14 1969-03-04 American Cyanamid Co Method for coating pharmaceutical forms with methyl cellulose
EP0283165A2 (en) * 1987-03-06 1988-09-21 The Procter & Gamble Company Skin conditioning composition and method
EP0283165A3 (en) * 1987-03-06 1990-05-16 The Procter & Gamble Company Skin conditioning composition and method
US4976953A (en) * 1987-03-06 1990-12-11 The Procter & Gamble Company Skin conditioning/cleansing compositions containing propoxylated glycerol derivatives
US5194464A (en) * 1988-09-27 1993-03-16 Takeda Chemical Industries, Ltd. Enteric film and preparatoin thereof

Similar Documents

Publication Publication Date Title
US4816259A (en) Process for coating gelatin capsules
US3539380A (en) Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
US3371015A (en) Pharmaceutical core compositions with thin rapidly disintegrating coatings
US2526683A (en) Methyl cellulose capsules and process of manufacture
US4880636A (en) Film coated tablet of ranitidine HCl
US5006362A (en) Branding pharmaceutical dosage forms, food and confectionery products with aqueous ingestible inks
US4138475A (en) Sustained release pharmaceutical composition
US3431138A (en) Method for coating pharmaceutical forms with methyl cellulose
EP0035780B1 (en) Coating compositions for enterosoluble solid dosage forms
HU225964B1 (en) Moisture barrier film coating composition, method, and coated form
US3097144A (en) Heat-cured, polymeric, medicinal dosage film coatings containing a polyvinylpyrrolidone copolymer, polyethenoid acid, and polyethylene glycol
US3390049A (en) Pharmaceutical tablets coated with wax-free ammonia solubilized water soluble shellac
US3054724A (en) Coloring discrete solids and compositions therefor
DE2146859A1 (en) Process for coating tablets with sugar
US2949402A (en) Tablet coating
US2491475A (en) Enteric capsule
JP4652052B2 (en) Film coating for tablets and caplets
US3297535A (en) Shellac tablet coating compositions and methods of preparation
US3524756A (en) Process of coating tablets with alternate tacky and non-tacky layers
US3149039A (en) Thin film coating for tablets and the like and method of coating
US3275518A (en) Tablet coating
US3407157A (en) Tablet coating compositions comprising methyl vinyl ethermaleic anhydride copolymer,plasticizer and surface active agent
US3149040A (en) Thin film coating for tablets and the like and method of coating
WO2002003967A1 (en) Film-coating composition based on cellulose derivatives and sugar alcohols
JPH07550B2 (en) Essential oil containing soft capsule